Centiva Capital’s Organon & Co OGN Stock Holding History

Centiva Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.38M	Buy	+250,000	New	+$2.99M	0.03%	333

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Centiva Capital's OGN Position: Q2 2026 in Review

Centiva Capital opened a new position in Organon & Co (OGN) in Q2 2026: 554,800 shares worth $7.51M. The stake represents 0.07% of the portfolio and ranks #207 among its holdings. This is a return to the name: Centiva Capital previously reported a position in OGN as recently as Q2 2025.

Centiva Capital first reported a position in OGN in Q3 2023 and has held it in 4 quarters since. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Centiva Capital held 554,800 shares of Organon & Co worth $7.51M as of Q2 2026.
Organon & Co was a new Centiva Capital position in Q2 2026.
Organon & Co made up 0.07% of Centiva Capital's portfolio in Q2 2026, its #207 holding.
Centiva Capital first reported a position in Organon & Co in Q3 2023 and has held it in 4 quarters since.
631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.